28-Randomised Controlled Trial-YangBF 09.5.12

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 14

23.

Randomised controlled trial


Dept. Epidemiology
School of Public Health
Jining Medical College
12 May 2009
Classification of mothod in epidemiology

 Descriptive epidemiology

 Analytical epidemiology

 Experimental studies or clinical trial

(Randomised controlled trial,RCT)


Destination

 To compare the effectiveness of a specific


treatment

 Preventional (or prophylactic) interventions


Principle of RCT

Example:

Group A (new anti-cancer drug) Length of survival


Side-effects
Group B (current treat) Quality of life

Some trials use three or more groups


 Placebo: non- treatment called a placebo. A placebo is
effectively a dummy treatment which appears to be real.

 Blind:The patients do not know whether they have been


allocated to the group receiving a new treatment, or an
old one, or a placebo.

 Double-blind RCT: Neither the patients nor the medical


staff know which intervention had been allocated.
 Cross-over trial
 Subjects receive one intervention for a certain period,

and then be changed over to another intervention.

 Multi-centre trials
 Studying subjects at more than one site

 Increase the sample size


 Meta-analysis :
 To summarize the results of several trials
 To “pool together” the results of trials
 Overall picture of an intervention’s efficacy

Drawbacks:
(1)publication bias: postive outcome more likely to be
published.
(2)quality of studies, quality of life and cost-
effectiveness are not normally evaluated

Systematic reviews: gold standard of clinical evidence


Study design

 Eligibility criteria:
patients who are most likely to benefit
from the treatment
they will not represent the whole population
of patients

 End of the trial


 changes in subjects’ condition, death or
other physical status
Follow up:until the end-point is reached.

Sample: calculated using formula.


 Ethical issues :
Subjects should not be exposed to known
or potential hazards
Unacceptable to withhold treatment from
subjects in a control group

Treaty of Helsinke
IRB approval
Informed consent
 Subjects

 The sample of subjects should be

representative of the population as a whole.


Randomly allocated to a particular treatment arm.

To ensure that their personal characteristics

have no influence over the treatment arm


 Data collection

Agreed points throughout the trial.


To check patient compliance with any treatments given,
including placebos.
Information about many factors,
including any side-effects of treatment.
 Data analysis

For continuous data: hypothesis tests,

confidence intervals.

For categorical data: Chi-squared test,

relative risk and

number needed to treat.

For other outcome variables


 Some advantages and disadvantages of
randomized controlled trials
Advantages Disadvantages
Allows effectiveness of a new Expensive and complicated to
treatment to be evaluated. perform.
Provides strong evidence of Patients may refuse treatment –
effectiveness. non-compliance can affect
results.
Less prone to confounding than A large sample size is needed.
other study designs.
Careful attention to ethical issues
is needed.
Informed patient consent is
essential.

You might also like